OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 90 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $636,346 | +12.1% | 51,526 | -18.0% | 0.00% | – |
| Q2 2023 | $567,599 | +43.6% | 62,857 | -44.8% | 0.00% | – |
| Q1 2023 | $395,198 | -20.5% | 113,890 | -43.9% | 0.00% | – |
| Q4 2022 | $497,159 | -37.3% | 202,922 | -29.4% | 0.00% | – |
| Q3 2022 | $793,000 | -55.3% | 287,504 | -34.1% | 0.00% | – |
| Q2 2022 | $1,776,000 | -31.1% | 436,432 | -27.9% | 0.00% | – |
| Q1 2022 | $2,579,000 | -53.5% | 605,260 | +2.2% | 0.00% | -100.0% |
| Q4 2021 | $5,544,000 | +133.6% | 592,325 | +587.8% | 0.00% | – |
| Q3 2021 | $2,373,000 | -32.2% | 86,124 | -31.2% | 0.00% | – |
| Q2 2021 | $3,501,000 | +71.6% | 125,160 | +103.7% | 0.00% | – |
| Q1 2021 | $2,040,000 | -7.3% | 61,458 | +34.3% | 0.00% | – |
| Q4 2020 | $2,201,000 | – | 45,768 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |